Lannett Co Inc (LCI): Price and Financial Metrics
LCI Price/Volume Stats
| Current price | $0.69 | 52-week high | $3.72 |
| Prev. close | $0.66 | 52-week low | $0.64 |
| Day low | $0.65 | Volume | 280,600 |
| Day high | $0.72 | Avg. volume | 92,067 |
| 50-day MA | $1.79 | Dividend yield | N/A |
| 200-day MA | $2.10 | Market Cap | 7.38M |
LCI Stock Price Chart Interactive Chart >
LCI Stock Summary
- LCI has a higher market value than only 2.64% of US stocks; more precisely, its current market capitalization is $7,105,934.
- LCI's price/sales ratio is 0.02; that's higher than the P/S ratio of only 0.33% of US stocks.
- The volatility of LANNETT CO INC's share price is greater than that of 97.23% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to LCI, based on their financial statements, market capitalization, and price volatility, are ERJ, ELAN, EGO, EMBC, and JMIA.
- LCI's SEC filings can be seen here. And to visit LANNETT CO INC's official web site, go to www.lannett.com.
LCI Valuation Summary
- In comparison to the median Healthcare stock, LCI's price/earnings ratio is 100% lower, now standing at 0.
- LCI's price/sales ratio has moved down 9 over the prior 243 months.
Below are key valuation metrics over time for LCI.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| LCI | 2023-04-17 | 0 | 0 | 0.0 | -4.4 |
| LCI | 2023-04-14 | 0 | 0 | 0.0 | -4.4 |
| LCI | 2023-04-13 | 0 | 0 | 0.0 | -4.4 |
| LCI | 2023-04-12 | 0 | 0 | 0.0 | -4.4 |
| LCI | 2023-04-11 | 0 | 0 | 0.0 | -4.4 |
| LCI | 2023-04-10 | 0 | 0 | -0.1 | -4.4 |
LCI Growth Metrics
- Its 2 year net income to common stockholders growth rate is now at -911.84%.
- Its 5 year price growth rate is now at -64.74%.
- Its 3 year net income to common stockholders growth rate is now at -14.62%.
The table below shows LCI's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-12-31 | 308.519 | -51.497 | -192.52 |
| 2022-09-30 | 314.133 | -35.653 | -237.297 |
| 2022-06-30 | 340.579 | -7.125 | -231.62 |
| 2022-03-31 | 372.399 | 38.531 | -316.211 |
| 2021-12-31 | 406.412 | 99.284 | -288.455 |
| 2021-09-30 | 453.824 | 90.275 | -379.318 |
LCI's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- LCI has a Quality Grade of C, ranking ahead of 38.22% of graded US stocks.
- LCI's asset turnover comes in at 0.579 -- ranking 62nd of 682 Pharmaceutical Products stocks.
- AWH, DRRX, and CLSN are the stocks whose asset turnover ratios are most correlated with LCI.
The table below shows LCI's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-30 | 0.579 | 0.146 | -0.243 |
| 2021-06-30 | 0.535 | 0.158 | -0.227 |
| 2021-03-31 | 0.507 | 0.181 | -0.193 |
| 2020-12-31 | 0.502 | 0.199 | -0.198 |
| 2020-09-30 | 0.473 | 0.272 | 0.008 |
| 2020-06-30 | 0.470 | 0.303 | 0.016 |
LCI Price Target
For more insight on analysts targets of LCI, see our LCI price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $6.00 | Average Broker Recommendation | 2 (Hold) |
Lannett Co Inc (LCI) Company Bio
Lannett Company develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications. The company was founded in 1942 and is based in Philadelphia, Pennsylvania.
Latest LCI News From Around the Web
Below are the latest news stories about LANNETT CO INC that investors may wish to consider to help them evaluate LCI as an investment opportunity.
Lannett CFO John Kozlowski to step down
|
LANNETT SHARES UPDATELannett Company, Inc. (NYSE: LCI) (the "Company") today shared a business update as it focuses on strategically positioning the Company to continue manufacturing and delivering safe, affordable, effective, life-enhancing generic pharmaceutical products for its valued patients and customers. |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayWe're beginning the day with a look at the biggest pre-market stock movers traders need to know about for Wednesday morning! |
7 Stocks to Sell as Borrowing Costs RiseWith new economic data boding poorly for risk-on investments, investors should strongly consider targeting stocks to sell. |
Recent uptick might appease Lannett Company, Inc. (NYSE:LCI) institutional owners after losing 26% over the past yearIf you want to know who really controls Lannett Company, Inc. ( NYSE:LCI ), then you'll have to look at the makeup of... |
LCI Price Returns
| 1-mo | N/A |
| 3-mo | -67.76% |
| 6-mo | -70.84% |
| 1-year | -67.64% |
| 3-year | -97.69% |
| 5-year | -98.97% |
| YTD | -66.88% |
| 2022 | -67.85% |
| 2021 | -75.15% |
| 2020 | -26.08% |
| 2019 | 77.82% |
| 2018 | -78.62% |
Continue Researching LCI
Want to see what other sources are saying about Lannett Co Inc's financials and stock price? Try the links below:Lannett Co Inc (LCI) Stock Price | Nasdaq
Lannett Co Inc (LCI) Stock Quote, History and News - Yahoo Finance
Lannett Co Inc (LCI) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...